文献速递冠心病外科

非ST段抬高型心肌梗死冠脉搭桥的理想时机

Ideal Timing of Coronary Artery Bypass Grafting After Non-ST-Segment Elevation Myocardial Infarction.
PubMed 文献 · Ann Thorac Surg · 2025-02-11

多中心区域协作研究纳入2011年7月至2023年7月间在心脏导管术后30天内接受孤立CABG的NSTEMI患者10271例,按手术时机分为≤2天、3-7天和8-30天三组。研究发现3-7天组手术死亡率和主要并发症最低,风险校正后该时间窗与死亡率降低独立相关,提示NSTEMI导管术后3-7天行CABG可能获得最佳结局。

要点

  • NSTEMI患者导管术后3-7天行CABG的手术死亡率最低(1.8%)。
  • ≤2天组更多合并左主干病变和心源性休克,风险校正后死亡率更高。
  • 风险校正后3-7天窗较≤2天和8-30天死亡率均显著降低。

核心结论

  • NSTEMI心脏导管术后3-7天行CABG与最低死亡风险相关,条件允许时该窗口可能带来更好结局。

研究设计与样本

  • 多中心区域协作回顾性研究,纳入2011年7月至2023年7月心脏导管术后30天内接受孤立CABG的NSTEMI患者10271例,按手术时机分为≤2天、3-7天、8-30天三组。

主要发现

  • 3-7天组手术死亡率最低(1.8% vs ≤2天组3.2% vs 8-30天组4%,P < .001)。
  • 3-7天组主要并发症最低(11% vs ≤2天组14% vs 8-30天组16%,P < .001)。
  • ≤2天组更多合并左主干病变(19% vs 16% vs 16%,P < .001)和心源性休克(5.1% vs 1.8% vs 2%,P < .001)。
  • 风险校正后3-7天窗较≤2天死亡率降低(OR 0.56,95%CI 0.4-0.78,P < .001)。
  • 风险校正后3-7天窗较8-30天死亡率降低(OR 0.51,95%CI 0.32-0.81,P < .001)。

关键数值与推荐

  • 3-7天组STS预测死亡风险中位数最低(1.36% vs 1.35% vs 2.09%,P < .001)。
  • 三组体外循环时间均值相似(97分钟 vs 97分钟 vs 97分钟,P = .63)。

临床怎么用

  • NSTEMI患者心脏导管术后如病情允许,可考虑在3-7天窗口内安排CABG以降低死亡和主要并发症风险。
  • 对≤2天手术者应关注左主干病变和心源性休克等高危因素并加强围术期管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with non-ST-segment elevation myocardial infarction (NSTEMI) benefit from revascularization, but guidelines are vague regarding optimal timing. This study aimed to identify the ideal timing of coronary artery bypass grafting (CABG) after NSTEMI. METHODS: Study investigators examined patients with NSTEMI who underwent isolated CABG within 30 days of cardiac catheterization between July 2011 and July 2023 in a multicenter regional collaborative. Patients were stratified into 3 groups: ≤2 days, 3 to 7 days, and 8 to 30 days. Multivariable logistic regression analysis was performed to identify risk factors associated with mortality. RESULTS: Study investigators identified 10,271 patients who underwent CABG: 3464 (34%) of these patients underwent CABG within ≤2 days, 5751 (56%) at 3 to 7 days, and 1056 (10%) at 8 to 30 days. The 3- to 7-day group had the lowest median The Society of Thoracic Surgeons predicted risk of mortality (1.36% vs 1.35% vs 2.09%; P < .001). The ≤2-day group more frequently presented with left main coronary artery disease (19% vs 16% vs 16%; P < .001) and cardiogenic shock (5.1% vs 1.8% vs 2%; P < .001). Mean cardiopulmonary bypass time was similar among the groups (97 minutes vs 97 minutes vs 97 minutes; P = .63). The 3- to 7-day group had the lowest operative mortality (3.2% vs 1.8% vs 4%; P < .001) and major morbidity (14% vs 11% vs 16%; P < .001). After risk-adjustment, the 3- to 7-day window was associated with decreased mortality compared with ≤2 days (odds ratio [OR], 0.56; 95% CI, 0.4-0.78; P < .001) and 8 to 30 days (OR, 0.51; 95% CI, 0.32-0.81; P < .001). CONCLUSIONS: CABG between 3 and 7 days after cardiac catheterization for NSTEMI was associated with the lowest risk of mortality. When possible, CABG within this window may afford better outcomes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Norman AV, Weber MP, El Moheb M, et al. Ideal Timing of Coronary Artery Bypass Grafting After Non-ST-Segment Elevation Myocardial Infarction. Ann Thorac Surg. 2025. PMID: 39947308. doi:10.1016/j.athoracsur.2025.01.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。